The Immune Checkpoint Inhibitor Landscape: Treatment Decision Making in Renal Cell Carcinoma (Part 1)

The Immune Checkpoint Inhibitor Landscape: Treatment Decision Making in Renal Cell Carcinoma (Part 1) is organized by Power-Pak C.E. - Continuing Education for Pharmacists & Pharmacy Technicians.

Published Date: May 31, 2019
Expiration Date: May 31, 2020

Credits: 0.5 hours (0.05 ceu)

Goal:
The goal of this education activity is to enhance oncology pharmacists’ skills and knowledge in the use of immune checkpoint inhibitors for the treatment of patients with renal cell carcinoma to optimize care and outcomes.

Educational Objectives:
At the conclusion of this activity, the learner will be better able to:
• Appraise current and emerging immuno-oncology agents and their roles in the treatment of renal cell carcinoma
• Describe the biomarkers being examined to predict response to immunotherapy

Additional details will be posted as soon as information is available.